Meso Numismatics completes acquisition of Global Stem Cells Group; financials show $105K net loss

Regenerative Medical Technology Group Inc.

Acquisition closed Aug 18, 2021: Meso Numismatics acquires GCSC for 1M Series AA pref, 8,974 Series DD pref, and $225K.
Change in control: Benito Novas receives Series AA super-voting stock (67% aggregate vote); CEO Christensen holds 50K Series AA.
GCSC's audited financials: 2020 revenue $615K (down from $1.02M in 2019), net loss $105K; $461K cash, $459K liabilities.
Going concern opinion: GCSC has recurring losses and working capital deficit, raising substantial doubt.

item 2.01 item 1.01 item 3.02 item 5.01 item 5.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.